Artificial nucleotide codons for enzymatic DNA synthesis.

Chem Commun (Camb)

Institut Pasteur, Université Paris Cité, CNRS UMR3523, Department of Structural Biology and Chemistry, Laboratory for Bioorganic Chemistry of Nucleic Acids, 28, rue du Docteur Roux, 75724 Paris Cedex 15, France.

Published: December 2023

AI Article Synopsis

  • The study presents a method for efficiently synthesizing both regular and chemically altered trinucleotide triphosphates (dNTPs).
  • This synthesis requires the use of phosphorothioate units to ensure stability for enzymatic DNA synthesis.
  • The ability to utilize three-letter codons instead of single-letter nucleotides is advantageous for creating xenonucleic acids (XNAs) and selecting modified nucleic acids with specific functions.

Article Abstract

Herein, we report the high-yielding solid-phase synthesis of unmodified and chemically modified trinucleotide triphosphates (dNTPs). These synthetic codons can be used for enzymatic DNA synthesis provided their scaffold is stabilized with phosphorothioate units. Enzymatic synthesis with three rather than one letter nucleotides will be useful to produce xenonucleic acids (XNAs) and for selection of modified functional nucleic acids.

Download full-text PDF

Source
http://dx.doi.org/10.1039/d3cc04933gDOI Listing

Publication Analysis

Top Keywords

codons enzymatic
8
enzymatic dna
8
dna synthesis
8
artificial nucleotide
4
nucleotide codons
4
synthesis
4
synthesis report
4
report high-yielding
4
high-yielding solid-phase
4
solid-phase synthesis
4

Similar Publications

Association of Novel Pathogenic Variant (p. Ile366Asn) in Gene with Infantile Neuroaxonal Dystrophy.

Int J Mol Sci

January 2025

Department of Human Genetics, School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA.

A couple presented to the office with an apparently healthy infant for a thorough clinical assessment, as they had previously lost two male children to a neurodegenerative disorder. They also reported the death of a male cousin abroad with a comparable condition. We aimed to evaluate a novel coding pathogenic variant c.

View Article and Find Full Text PDF

Alginate, a polysaccharide found in brown seaweeds, has regularly gained attention for its potential use as a source of bioactive compounds. However, it is structurally complex with a high molecular weight, limiting its application. Alginate oligosaccharides (AOS) are small, soluble fragments, making them more bioavailable.

View Article and Find Full Text PDF

Heterologous expression and enzymological characterization of L-glutamate oxidase from the marine actinomycete Streptomyces lydicamycinicus NBRC 110027.

Biosci Biotechnol Biochem

December 2024

Department of Life Science and Biotechnology, Faculty of Chemistry, Materials and Bioengineering, Kansai University, 3-3-35 Yamate-Cho, Suita, Osaka-Fu 564-8680, Japan.

We successfully constructed a heterologous expression system for L-glutamate oxidase from the marine actinomycete Streptomyces lydicamycinicus NBRC 110027 (Sl-LGOX) in Escherichia coli BL21(DE3) as a host. This is the first example of L-glutamate oxidase from a marine microorganism. A chemically synthesized gene optimized for codon usage in E.

View Article and Find Full Text PDF

Phosphorylation-mediated conformational change regulates human SLFN11.

Nat Commun

December 2024

Gene Center and Department of Biochemistry, Ludwig-Maximilians-Universität München, Feodor-Lynen Straße 25, 81377, Munich, Germany.

Human Schlafen 11 (SLFN11) is sensitizing cells to DNA damaging agents by irreversibly blocking stalled replication forks, making it a potential predictive biomarker in chemotherapy. Furthermore, SLFN11 acts as a pattern recognition receptor for single-stranded DNA (ssDNA) and functions as an antiviral restriction factor, targeting translation in a codon-usage-dependent manner through its endoribonuclease activity. However, the regulation of the various SLFN11 functions and enzymatic activities remains enigmatic.

View Article and Find Full Text PDF

Identification, heterologous expression, and characterisation of β-1,3-xylanase BcXyn26B from human gut bacterium Bacteroides cellulosilyticus WH2.

Biotechnol Lett

December 2024

Department of Life Sciences, Graduate School of Bioresources, Mie University, 1577 Kurimamachiya, Tsu, Mie, 514-8507, Japan.

The cell walls of red and green algae contain β-1,3-xylan, which is hydrolysed by the endo-type enzyme β-1,3-xylanase. Notably, only marine-bacteria-derived β-1,3-xylanases have been functionally characterised to date. In this study, we characterised the enzymatic properties of a potential β-1,3-xylanase (BcXyn26B) derived from the human gut bacterium, Bacteroides cellulosilyticus WH2.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!